Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polypoidal Choroidal Vasculopathy”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Not applicableUnknownNCT01360151
What this trial is testing

Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Seoul St. Mary's Hospital 16
Testing effectiveness (Phase 2)WithdrawnNCT03374670
What this trial is testing

ZIMURA in Combination With Eylea in Patients With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV)

Who this might be right for
Idiopathic Polypoidal Choroidal Vasculopathy
Ophthotech Corporation
Not applicableStudy completedNCT05229237
What this trial is testing

Conbercept for Polypoidal Choroidal Vasculopathy（START Study）

Who this might be right for
Polypoidal Choroidal VasculopathyConbercept
Peking Union Medical College Hospital 500
Post-approval studies (Phase 4)UnknownNCT03159884
What this trial is testing

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)
Chengdu Kanghong Biotech Co., Ltd. 300
Large-scale testing (Phase 3)Looking for participantsNCT07461441
What this trial is testing

Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Age Related Macular Degeneration
Yeungnam University College of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT01884597
What this trial is testing

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)

Who this might be right for
PCVPolypoidal Choroidal Vasculopathy
Hawaii Pacific Health 24
Post-approval studies (Phase 4)Study completedNCT02072408
What this trial is testing

Efficacy and Safety of Intravitreal Vascular Endothelial Growth Factor Trap-eye in Patients With Polyploidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy Without Active Polyp
Samsung Medical Center 46
Post-approval studies (Phase 4)Study completedNCT02495181
What this trial is testing

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 50
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableStudy completedNCT04075188
What this trial is testing

Treatment of Polypoidal Choroidal Vasculopathy in Pachychoroid

Who this might be right for
Choroidal NeovascularizationChoroid Disease
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo 17
Not applicableLooking for participantsNCT02141308
What this trial is testing

OCT in Rare Chorioretinal Diseases

Who this might be right for
Retinal Artery OcclusionsPolypoidal Choroidal VasculopathyRetinal Arterial Macroaneurysm+2 more
Oregon Health and Science University 150
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Post-approval studies (Phase 4)Study completedNCT03117634
What this trial is testing

An Open Label-study to Compare the Efficacy of Aflibercept Monotherapy for Polypoidal Choroidal Vasculopathy

Who this might be right for
Age Related Macular DegenerationPolypoidal Choroidal Vasculopathy
Singapore National Eye Centre 54
Testing effectiveness (Phase 2)Study completedNCT00837330
What this trial is testing

Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Post-approval studies (Phase 4)Not Yet RecruitingNCT07365371
What this trial is testing

A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 174
Post-approval studies (Phase 4)Study completedNCT01871376
What this trial is testing

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

Who this might be right for
Polypoidal Choroidal Vasculopathy
Gregg T. Kokame, MD 25
Not applicableUnknownNCT05639660
What this trial is testing

Clinical Implication of Aflibercept in PCV Treatment in China

Who this might be right for
Polypoidal Choroidal Vasculopathy
Peking Union Medical College Hospital 1,000
Large-scale testing (Phase 3)Ended earlyNCT02769169
What this trial is testing

Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Sun Yat-sen University 5
Post-approval studies (Phase 4)UnknownNCT02681783
What this trial is testing

PRedictive Factors and Changes From Treatment in iPCV Versus CSR Versus nAMD With afLibercept

Who this might be right for
Central Serous ChorioretinopathyAge Related Macular DegenerationIdiopathic Poplypoidal Choroidal Vasculopathy
Sunnybrook Health Sciences Centre 90
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Load More Results